Long noncoding RNA DARS-AS1 acts as an oncogene by targeting miR-532-3p in ovarian cancer.

OBJECTIVE Ovarian cancer is one of the most ordinary malignant tumors. Recently, the role of long noncoding RNAs (lncRNAs) in tumor progression has caught attention of numerous researchers. In this research, lncRNA DARS-AS1 was studied to identify how it functions in the development of ovarian cancer. PATIENTS AND METHODS DARS-AS1 expression was detected by Real-time quantitative polymerase chain reaction (RT-qPCR) in ovarian cancer tissue samples. Moreover, functional experiments were conducted to detect the effect of DARS-AS1 on the proliferation and metastasis of ovarian cancer. In addition, the underlying mechanism was explored through luciferase assay and RNA immunoprecipitation (RIP) assay. RESULTS In this study, DARS-AS1 expression was remarkably higher in ovarian cancer tissues compared with that in adjacent ones. Cell proliferation was inhibited after DARS-AS1 silenced in ovarian cancer cells. Moreover, cell migration and invasion were also inhibited after DARS-AS1 silenced in ovarian cancer cells. Furthermore, results of luciferase assays and RIP assay showed that microRNA-532-3p (miR-532-3p) was a direct target of DARS-AS1 in ovarian cancer. The expression of miR-532-3p was upregulated after DARS-AS1 was knocked down. CONCLUSIONS Our study suggests that DARS-AS1 enhances cell proliferation and metastasis via sponging miR-532-3p in ovarian cancer.

[1]  Wei Chen,et al.  Downregulation of microRNA-532-5p promotes the proliferation and invasion of bladder cancer cells through promotion of HMGB3/Wnt/β-catenin signaling. , 2019, Chemico-biological interactions.

[2]  Q. Wen,et al.  LncRNA SNHG16 drives proliferation and invasion of papillary thyroid cancer through modulation of miR-497 , 2019, OncoTargets and therapy.

[3]  Yuekui Jian,et al.  MiR-532 downregulation of the Wnt/β-catenin signaling via targeting Bcl-9 and induced human intervertebral disc nucleus pulposus cells apoptosis. , 2018, Journal of pharmacological sciences.

[4]  L. Fu,et al.  Long non-coding RNA FENDRR inhibits NSCLC cell growth and aggressiveness by sponging miR-761. , 2018, European review for medical and pharmacological sciences.

[5]  Cong Zhao,et al.  Long noncoding RNA MEG3 inhibits proliferation and migration but induces autophagy by regulation of Sirt7 and PI3K/AKT/mTOR pathway in glioma cells , 2018, Journal of cellular biochemistry.

[6]  Hongyan Wang,et al.  Research on correlations of ERCC-1 with proliferation and apoptosis of ovarian cancer cells. , 2018, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

[7]  Xiaoping Zhou,et al.  The lncRNA TUG1 promotes epithelial ovarian cancer cell proliferation and invasion via the WNT/β-catenin pathway , 2018, OncoTargets and therapy.

[8]  Zhengyan Zhang,et al.  Knockdown of long non-coding RNA HOTAIR increases cisplatin sensitivity in ovarian cancer by inhibiting cisplatin-induced autophagy. , 2018, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

[9]  K. Hua,et al.  ElncRNA1, a long non-coding RNA that is transcriptionally induced by oestrogen, promotes epithelial ovarian cancer cell proliferation. , 2017, International journal of oncology.

[10]  Wei Zhou,et al.  miR‐532 promoted gastric cancer migration and invasion by targeting NKD1 , 2017, Life sciences.

[11]  Xinrui Zhao,et al.  Long Noncoding RNA MNX1-AS1 Knockdown Inhibits Cell Proliferation and Migration in Ovarian Cancer. , 2017, Cancer biotherapy & radiopharmaceuticals.

[12]  Jie Bai,et al.  MicroRNA-532 and microRNA-3064 inhibit cell proliferation and invasion by acting as direct regulators of human telomerase reverse transcriptase in ovarian cancer , 2017, PloS one.

[13]  Suwei Wang,et al.  Long non-coding RNA BACE1-AS is a novel target for anisomycin-mediated suppression of ovarian cancer stem cell proliferation and invasion. , 2016, Oncology reports.

[14]  Fan Wang,et al.  High Expression of miR-532-5p, a Tumor Suppressor, Leads to Better Prognosis in Ovarian Cancer Both In Vivo and In Vitro , 2016, Molecular Cancer Therapeutics.

[15]  A. Jemal,et al.  Cancer statistics, 2012 , 2012, CA: a cancer journal for clinicians.

[16]  M. McKay,et al.  Cancer of the ovary. , 1994, The New England journal of medicine.